Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,122,625
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2,481,066
-
Shares change
-
-209,937
-
Total reported value, excl. options
-
$23,335,869
-
Value change
-
-$1,872,873
-
Number of buys
-
9
-
Number of sells
-
7
-
Price
-
$9.40
Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2022
As of 31 Mar 2022 LUMOS PHARMA INC - Common Stock (LUMO) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,481,066 shares of stock of the company.
Largest 10 holders included Blackstone Inc., GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Jefferies Group LLC, BlackRock Inc., and Lion Point Capital, LP.
This table shows 31 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.